Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Turkish Version of Childhood Bladder and Bowel Dysfunction Questionnaire

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03742570
Recruitment Status : Completed
First Posted : November 15, 2018
Last Update Posted : November 19, 2018
Sponsor:
Information provided by (Responsible Party):
Gamze Tosun Aydin, Okan University

Brief Summary:

Objectives:The aim of this study was to translate the Childhood Bladder and Bowel Dysfunction Questionnaire into Turkish, adapt it for use with parents of 5-12 year old children and determine the reliability and construct validity of the Turkish version. The main hypothesis of our study was that it would be possible to translate and culturally adapt the CBBDQ into a Turkish version, so that Turkish parents could understand it. Additionally, we hypothesized that the Turkish version would provide adequate internal consistency and test-rest reliability and acceptable construct validity.

Methods:The Childhood Bladder and Bowel Dysfunction Questionnaire was guideline driven translated into Turkish and administered twice, at 7-day intervals, to parents of children to assess test-retest reliability. Cronbach's α was used for internal consistency and the inter-rater correlation coefficient was used to calculate test-retest reliability. The Dysfunctional Voiding and Incontinence Scoring System (DVISS) and Pediatric Quality of Life Inventory (PedsQL) in 5-7, 8-12 years old children were used as an external criterion to estimate construct validity.


Condition or disease Intervention/treatment
Children Behavioral: CBBDQ

  Show Detailed Description

Layout table for study information
Study Type : Observational
Actual Enrollment : 85 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: The Turkish Version of The Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ): Cross-Cultural Adaptation, Reliability and Construct Validity
Actual Study Start Date : April 13, 2016
Actual Primary Completion Date : June 15, 2018
Actual Study Completion Date : October 15, 2018

Group/Cohort Intervention/treatment
CBBDQ
A Questionnaire
Behavioral: CBBDQ
a questionnaire for childood bladder and bowel dysfunctions




Primary Outcome Measures :
  1. DVISS [ Time Frame: 2017-2018 ]
    The DVISS is a 14-item questionnaire originally designed in Turkish with the aim to diagnose patients with dysfunctional voiding. The DVISS includes 12 questions on bladder dysfunction, one on bowel dysfunctions and one on quality of life and has variable (Likert scales, dichotomous) answering options. The total score ranged from 0 to 35 points; sum scores higher from 9 points indicate increased disease severity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
The study was conducted as a questionnaire-based cross-sectional survey of parents of children (5-12y) with urinary incontinence, enuresis, constipation/fecal incontinence.
Criteria

Inclusion Criteria:

  • parents of children, aged between 5 to 12 years;
  • whose children suffered from urinary incontinence, enuresis nocturia, constipation/fecal incontinence;
  • parents and children read and approved the informed consent form.

Exclusion Criteria:

  • the presence of urinary tract infection;
  • patients having spinal cord injury or neurological disease;
  • not being able to communicate.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03742570


Sponsors and Collaborators
Okan University
Investigators
Layout table for investigator information
Principal Investigator: Gamze Aydin, MSc Okan University

Layout table for additonal information
Responsible Party: Gamze Tosun Aydin, Principal Investigator, Okan University
ClinicalTrials.gov Identifier: NCT03742570     History of Changes
Other Study ID Numbers: OkanUn
First Posted: November 15, 2018    Key Record Dates
Last Update Posted: November 19, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Gamze Tosun Aydin, Okan University:
Childhood Bladder and Bowel Dysfunction Questionnaire
Reliability
Turkish
Additional relevant MeSH terms:
Layout table for MeSH terms
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases